You are not logged in.

Thromboyytic therapy for acute ischaemic stroke : successful implementation in an Australian tertiary hospital

Bray, Janet, Coughlan, Kelly and Bladin, Christopher 2006, Thromboyytic therapy for acute ischaemic stroke : successful implementation in an Australian tertiary hospital, Internal medicine journal, vol. 36, no. 8, pp. 483-488, doi: 10.1111/j.1445-5994.2006.01127.x.

Attached Files
Name Description MIMEType Size Downloads

Title Thromboyytic therapy for acute ischaemic stroke : successful implementation in an Australian tertiary hospital
Author(s) Bray, Janet
Coughlan, Kelly
Bladin, Christopher
Journal name Internal medicine journal
Volume number 36
Issue number 8
Start page 483
End page 488
Publisher Wiley-Blackwell Publishing Asia
Place of publication Richmond, Vic.
Publication date 2006-08
ISSN 1444-0903
1445-5994
Keyword(s) stroke
cerebrovascular accident
thrombolytic therapy
tissue plasminogen activator
Australia
Summary Background: The use of tissue-type plasminogen activator (t-PA) in ischaemic stroke outside of experienced stroke centres remains controversial. The aim of this study was to present the initial experience with t-PA in patients with ischaemic stroke at an institution with no prior experience in i.v. stroke thrombolysis and to compare results to published reports.

Methods: Prospective audit of 888 patients with consecutive stroke and transient ischaemic attack admitted to a 426-bed tertiary referral hospital from March 2003 to October 2005. Main outcome measures were treatment rate, exclusion criteria, protocol violations, intracerebral haemorrhage, disability (modified Rankin scale) and mortality at 3 months.

Results: Over the study period, 72 patients received t-PA (11% of ischaemic strokes). The main reason for exclusion was presentation beyond 3 h of onset (44%); if all eligible patients had arrived within 3 h, treatment rate was estimated at 32.5%. Protocol violations occurred in 15 (21%) patients. There were seven (10%) asymptomatic intracerebral haemorrhage and one (1%) non-fatal symptomatic intracerebral haemorrhage. At 3 months, 37% had achieved excellent recovery (modified Rankin scale 0–1) and seven (10%) had died. The delivery and outcomes associated with the use of t-PA were comparable to the results of the National Institute of Neurological Disorders and Stroke trial and meta-analysis of open-labelled studies.

Conclusion: With appropriate infrastructure and protocols, previously inexperienced tertiary referral centres can replicate the experience and outcome measures reported by clinical trials of t-PA in patients with stroke.
Language eng
DOI 10.1111/j.1445-5994.2006.01127.x
Field of Research 111004 Clinical Nursing: Tertiary (Rehabilitative)
HERDC Research category C1.1 Refereed article in a scholarly journal
Copyright notice ©2006, The Authors
Persistent URL http://hdl.handle.net/10536/DRO/DU:30022493

Document type: Journal Article
Collection: School of Nursing and Midwifery
Connect to link resolver
 
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.

Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 26 times in TR Web of Science
Scopus Citation Count Cited 28 times in Scopus
Google Scholar Search Google Scholar
Access Statistics: 354 Abstract Views, 0 File Downloads  -  Detailed Statistics
Created: Tue, 19 Jan 2010, 13:52:36 EST

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.